Código QR (código de barras bidimensional)

Personalised treatment of patients with immune thrombotic thrombocytopenic purpura

Background. Treatment of immune thrombotic thrombocytopenic purpura (iTTP) includes plasma exchange (PEX) and immunosuppression (glucocorticoids and rituximab). The addition of caplacizumab to therapy has improved treatment outcomes in iTTP. However, the available therapies focus on the duration of...

ver descrição completa

Na minha lista:
Principais autores: Gennady M. Galstyan, Elizaveta E. Klebanova, Svetlana Yu. Mamleeva, Pavel V. Avdonin, Zalina T. Fidarova, Mikhail Yu. Drokov, Elena N. Parovichnikova
Formato: Artigo
Idioma:Russo
Publicado em: "Consilium Medicum" Publishing house 2025-01-01
coleção:Терапевтический архив
Assuntos:
thrombotic thrombocytopenic purpura
adamts13
plasma exchange
glucocorticoids
caplacizumab
rituximab
bortezomib
Acesso em linha:https://ter-arkhiv.ru/0040-3660/article/viewFile/680623/205519
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados